PlainRecalls
FDA Drug Critical Class I Terminated

Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV

Reported: August 3, 2022 Initiated: July 5, 2022 #D-1292-2022

Product Description

Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV

Reason for Recall

Labeling: Missing label: Label missing from some prefilled pens.

Details

Recalling Firm
Mylan Pharmaceuticals Inc
Units Affected
253,200 pens (50,650/5 per packs)
Distribution
Product was distributed nationwide within the United States
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV. Recalled by Mylan Pharmaceuticals Inc. Units affected: 253,200 pens (50,650/5 per packs).
Why was this product recalled?
Labeling: Missing label: Label missing from some prefilled pens.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 3, 2022. Severity: Critical. Recall number: D-1292-2022.